Avatrombopag is a prescription drug used to treat thrombocytopenia or immune thrombocytopenia associated with chronic liver disease. The specific cost is affected by factors such as dosage, region, and medical insurance policies, and should be confirmed with the actual purchasing channel.
Detailed Explanation of Price:
Price Influencing Factors:
Different dosages (e.g., number of tablets or dosage) directly affect the total price. Please verify the drug information before purchasing.
In some regions, the drug is covered by medical insurance or local supplementary insurance. After reimbursement, the out-of-pocket portion may be reduced by 30%-50%. Consult your local hospital or medical insurance department.
Prices may differ between hospitals and pharmacies. It is recommended to purchase through official channels.
Precautions for Use:
This is a prescription drug and must be used strictly according to your doctor's instructions. Do not adjust the dosage or discontinue use without consulting your doctor.
Regular monitoring of platelet count is necessary during treatment to avoid the risk of thrombosis.**
Patients with chronic liver disease should have their liver function indicators assessed for drug safety.**
Other Cost-Related Advice:
Some charitable organizations or pharmaceutical companies offer patient assistance programs. Follow official information or apply through your attending physician.
Imported and domestically produced generic drugs have significantly different prices; the choice should be based on clinical needs and doctor's advice.
If medication is required, it is recommended to consult a hematologist or hepatobiliary specialist for an assessment of your condition and to obtain a prescription. Purchase the medication through compliant channels. Drug prices may be subject to policy adjustments; the price at the time of purchase will prevail.
